Drug Type Small molecule drug |
Synonyms HP 560, HP560 |
Target |
Action inhibitors |
Mechanism BET inhibitors(Bromodomain and extra terminal domain protein inhibitors), Epigenetic drug |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myelofibrosis | IND Approval | China | 23 Jul 2024 | |
Hematologic Neoplasms | Preclinical | China | 05 Sep 2023 | |
Multiple Myeloma | Preclinical | China | 05 Sep 2023 | |
Triple Negative Breast Cancer | Preclinical | China | 05 Sep 2023 |